Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease?
- 27 June 2012
- Vol. 98 (14), 1055-1062
- https://doi.org/10.1136/heartjnl-2012-301759
Abstract
Significant cardiac morbidity and mortality exists in patients with COPD. Shared risk factors include age, smoking history and exposure to air pollution and passive smoke. Although the inappropriate under-prescribing of β-blockers contributes, it is now appreciated that the observed cardiac risk is not only due to smoking and conventional cardiovascular risk factors, but also other independent factors. A number of hypotheses exist for the increased cardiovascular morbidity and mortality seen in COPD including inflammation, pulmonary hypertension, lung hyperinflation and shared genetics models. Mounting evidence from large randomised controlled trials suggests that COPD treatment may be cardio-protective. We review the current evidence supporting the aforementioned hypotheses and how their modulation may prevent cardiovascular morbidity and mortality in COPD. The persisting underdiagnosis of COPD may have significant consequences. Further mechanistic studies identifying the onset and impact of individual interventions will develop our understanding of this emerging and highly relevant clinical field.Keywords
This publication has 143 references indexed in Scilit:
- Lung deflation and oxygen pulse in COPD: Results from the NETT randomized trialRespiratory Medicine, 2012
- Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary diseaseBritish Journal of Pharmacology, 2011
- Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regenerationEuropean Heart Journal, 2010
- Soluble Epoxide Hydrolase in AtherosclerosisCurrent Atherosclerosis Reports, 2010
- The impact of a 100% smoke-free law on the health of hospitality workers from the city of Neuquen, ArgentinaTobacco Control, 2010
- Percent Emphysema, Airflow Obstruction, and Impaired Left Ventricular FillingNew England Journal of Medicine, 2010
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2008
- Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint CommitteeThorax, 2007
- The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosisJournal of Medical Genetics, 2006
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993